Literature DB >> 27149265

Human Vaccines & Immunotherapeutics: News.

.   

Abstract

Entities:  

Year:  2016        PMID： 27149265      PMCID： PMC4964678          DOI： 10.1080/21645515.2016.1160701

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  2 in total

1.  Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses.

Authors:  Julia C Frei; Elisabeth K Nyakatura; Samantha E Zak; Russell R Bakken; Kartik Chandran; John M Dye; Jonathan R Lai
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

2.  Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.

Authors:  Milagritos D Tapia; Samba O Sow; Kirsten E Lyke; Fadima Cheick Haidara; Fatoumata Diallo; Moussa Doumbia; Awa Traore; Flanon Coulibaly; Mamoudou Kodio; Uma Onwuchekwa; Marcelo B Sztein; Rezwanul Wahid; James D Campbell; Marie-Paule Kieny; Vasee Moorthy; Egeruan B Imoukhuede; Tommy Rampling; Francois Roman; Iris De Ryck; Abbie R Bellamy; Len Dally; Olivier Tshiani Mbaya; Aurélie Ploquin; Yan Zhou; Daphne A Stanley; Robert Bailer; Richard A Koup; Mario Roederer; Julie Ledgerwood; Adrian V S Hill; W Ripley Ballou; Nancy Sullivan; Barney Graham; Myron M Levine
Journal:  Lancet Infect Dis       Date:  2015-11-04       Impact factor: 25.071
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.